A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.

A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.

A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.

A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.

A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.

Methods for treating pain are disclosed which comprise administration of a therapeutically effective amount of an amylin or an amylin agonist alone or in conjunction with a narcotic analgesic for example morphine or pentazocine.

The analgesic effectiveness of a narcotic agonist-antagonist analgesic is significantly potentiated by administering a narcotic agonist-antagonist analgesic together with at least one nontoxic NMDA recept or antagonist. The narcotic agonist-antagonist analgesic is selected from the group consisting of pentazocine nalbuphine butorphanol buprenorphine meptazinol dezocine nalorphine cyclazocine and pharmaceutically acceptable salts thereof. The nontoxic NMDA receptor antagonist is at least one memb...

PROBLEM TO BE SOLVED: To provide a method of easily separating and collecting the subject compound useful as a medicine in high yield and purity by use of a specific optical resolution agent in the presence of a solvent.SOLUTION: This method (1) dissolves 1mol equivalent of pentazocine and 0.25 to 1mol equivalent of (+)- or (-)-di-p-toluoyltartaric acid in a solvent (preferably an alcohol or a mixture thereof with water or acetone or a mixture thereof with water) in a quantity that can completel...

A pharmaceutical composition comprising an analgesic or analgesic combination and a stool softener is disclosed. The analgesic is selected from morphine meperidine fentanyl hydromorphone oxymorphone oxycodone hydrocodone methadone propoxyphene pentazocine levorphanol codeine acetaminophen and combinations of these analgesics. The composition is formulated for oral administration as a liquid or solid dosage form for immediate slow delayed or sustained-release characteristics.